Consensus guidelines in the treatment of major depressive disorder

Journal of Clinical Psychiatry

Volumn 59, Issue SUPPL. 20, 1998, Pages 73-84

  Rush, A John ^a,d   Crismon, M Lynn ^b   Toprac, Marcia G ^c   Trivedi, Madhukar H ^a   Rago, William V ^c   Shon, Steve ^c   Altshuler, Kenneth Z ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c Texas Department of Mental Health and Mental Retardation   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PAROXETINE; SERTRALINE;

ALGORITHM; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; HEALTH CARE QUALITY; HUMAN; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

ALGORITHMS; ANTIDEPRESSIVE AGENTS; CLINICAL PROTOCOLS; DECISION TREES; DEPRESSIVE DISORDER; DRUG ADMINISTRATION SCHEDULE; HUMANS; PATIENT EDUCATION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; QUALITY OF HEALTH CARE;

EID: 0032434360     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Agency for Health Care Policy and Research. Clinical Practice Guideline, No. 5: Depression in Primary Care, vol 2, Treatment of Major Depression. AHCPR publication 93-0551. Rockville, Md: US Dept Health and Human Services; April 1993
2. Agency for Health Care Policy and Research. Clinical Practice Guideline, No. 5: Depression in Primary Care, vol 1, Detection and Diagnosis. AHCPR publication 93-0550. Rockville, Md: US Dept Health and Human Services; April 1993
3. American Psychiatric Association. Practice guidelines for major depressive disorder in adults. Am J Psychiatry 1993;150(4, suppl):1-26
4. Rush AJ, Trivedi MH. Treating depression to remission. Psychiatr Ann 1995; 704-705, 709
5. Rush AJ, Prien R. From scientific knowledge to the clinical practice of psychopharmacology: can the gap be bridged? Psychopharmacol Bull 1995; 31:7-20
6. Katon W, Robinson P, Von Korff M, et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry 1996;53:924-932
7. Field MJ, Lohr KN. Clinical Practice Guidelines: Directions for a New Program. US Institute of Medicine Committee to Advise the Public Health Service on Clinical Practice Guidelines, US Dept Health and Human Services. Washington, DC: National Academy Press; 1990
8. Diamond LH. Developing disease-specific drug treatment protocols. In: Manolakis PG, ed. APhA Guide to Drug Treatment Protocols: A Resource for Creating and Using Disease Specific Pathways. Washington, DC: American Pharmaceutical Association; 1996:6-1-6-14
9. Rush AJ. Linking efficacy and effectiveness research in the evaluation of psychotherapies. In: Miller NE, Magruder KM, eds. The Cost Effectiveness of Psychotherapy: A Guide for Practitioners, Researchers and Policy-makers. New York, NY: John Wiley & Sons. In press
10. Rupp A. The economic consequences of not treating depression. Br J Psychiatry 1995;166(suppl 27):29-38
11. Lane R, McDonald G. Reducing the economic burden of depression. Int Clin Psychopharmacol 1994;9:229-243
12. Rush AJ, Clayton PJ, Galle B, et al. Consensus Conference. Length of Antidepressant Therapy. Conference Proceedings. Little Falls, NJ: Health Learning Systems, Inc; 1996:1-28
13. Rush AJ, Gullion CM, Roffwarg HP, et al. When do patients respond to tricyclic antidepressants? [abstract] Biol Psychiatry 1994;35:711
14. Nierenberg AA, McNeal NE, Alpert JE, et al. Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. Am J Psychiatry 1995;152:-1500-1503
15. Rey JA, Crismon ML, Dopheide JA, et al. Management of major depression in adults. In: Manolakis PG, ed. APhA Guide to Drug Treatment Protocols: A Resource for Creating and Using Disease Specific Pathways. Washington, DC: American Pharmaceutical Association; 1996: MDi-MD11
16. Fava M, Rosenbaum JF. Pharmacotherapy and somatic therapies. In: Beckham EE, Leber WR, eds. Handbook of Depression. 2nd ed. New York, NY: Guilford Press; 1995:280-301
17. Hirschfeld RMA, Keller MB, Panico S, et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA 1997;277:333-340
18. Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA 1995; 273:1026-1031
19. Prusoff BA, Klerman GL, Paykel ES. Concordance between clinical assessments and patients' self-report in depression. Arch Gen Psychiatry 1972;26:546-552
20. Katon W, Von Korff M, Lin E, et al. Population-based care of depression: effective disease management strategies to decrease prevalence. Gen Hosp Psychiatry. In press
21. Basco MR, Rush AJ. Compliance with pharmacotherapy in mood disorders. Psychiatr Ann 1995;25:269-270,276,278-279
22. National Alliance for Research on Schizophrenia and Depression. Conquering Depression. Great Neck, NY: NARSAD Research; 1996
23. New York State Psychiatric Association. Treating Major Depression: A Patient's Guide. New York, NY: New York State Psychiatric Association; 1996
24. Lin EBH, Katon W, Simon G, et al. Achieving guidelines for the treatment of depression in primary care: is physician education enough? Med Care. In press
25. McCombs JS, Nichol MB, Stimmel GL, et al. The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid population. J Clin Psychiatry 1990;51(6, suppl):60-69
26. Sclar DA, Robison LM, Skaer TL, et al. Antidepressant pharmacotherapy: economic outcomes in a health maintenance organization. Clin Ther 1994; 16:715-730
27. Skaer TL, Sclar DA, Robison L, et al. Economic valuation of amitriptyline, desipramine, nortriptyline, and sertraline in the management of patients with depression. Curr Ther Res 1995;56:556-567
28. Simon GE, Von Korff M, Heiligenstein JH, et al. Initial antidepressant choice in primary care: effectiveness and cost of fluoxetine vs tricyclic antidepressants. JAMA 1996;275:1897-1902
29. Revicki DA, Brown RE, Keller MB, et al. Cost-effectiveness of newer antidepressants compared with tricyclic antidepressants in managed care settings. J Clin Psychiatry 1997;58:47-58